Targets TR Xx (TCY) Cotización

This is awesome. Thanks TJ. Need a lot of patience.

georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr

Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.

TJ that’s better dream :)) OS dream big :))

Thx, brother. 👍

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET

That's where, at the very least, Steven Walker should have been present. But he wasn't...

Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty

In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?

$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It

We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/

Ceo Mark White is in rehab for drug addiction

That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th

Soon.

that would be a wasted call...lol

*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID

Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.

Hopefully, we can beat yesterday volume. Lol

Now from 100 to 500m?